Investigative Ophthalmology & Visual Science Cover Image for Volume 65, Issue 7
June 2024
Volume 65, Issue 7
Open Access
ARVO Annual Meeting Abstract  |   June 2024
A new method for measuring spatial contrast sensitivity in central and peripheral retinal diseases
Author Affiliations & Notes
  • Prakash Adhikari
    Melanopsin Photoreception & Visual Science Laboratories, Centre for Vision & Eye Research, Queensland University of Technology, Brisbane, Queensland, Australia
  • Beatrix Feigl
    Melanopsin Photoreception & Visual Science Laboratories, Centre for Vision & Eye Research, Queensland University of Technology, Brisbane, Queensland, Australia
    School of Biomedical Sciences, Queensland University of Technology, Brisbane, Queensland, Australia
  • Andrew J. Zele
    Melanopsin Photoreception & Visual Science Laboratories, Centre for Vision & Eye Research, Queensland University of Technology, Brisbane, Queensland, Australia
  • Footnotes
    Commercial Relationships   Prakash Adhikari None; Beatrix Feigl None; Andrew Zele None
  • Footnotes
    Support  Australian Research Council ARC-FT180100458 (AJZ)
Investigative Ophthalmology & Visual Science June 2024, Vol.65, 6343. doi:
  • Views
  • Share
  • Tools
    • Alerts
      ×
      This feature is available to authenticated users only.
      Sign In or Create an Account ×
    • Get Citation

      Prakash Adhikari, Beatrix Feigl, Andrew J. Zele; A new method for measuring spatial contrast sensitivity in central and peripheral retinal diseases. Invest. Ophthalmol. Vis. Sci. 2024;65(7):6343.

      Download citation file:


      © ARVO (1962-2015); The Authors (2016-present)

      ×
  • Supplements
Abstract

Purpose : Contrast sensitivity loss in early retinal and optic nerve diseases is often spatial frequency selective. Here we determine the sensitivity of a new spatial contrast sensitivity (SCS) vision chart [Adhikari, Carter, Feigl & Zele, 2022, 2023] for detecting photopic and mesopic visual abnormalities compared to high contrast visual acuity.

Methods : We recruited 99 people, including 54 patients with eye conditions (9 people with diabetes without diabetic retinopathy, 10 with early age-related macular degeneration (AMD), 24 glaucoma suspects, 11 high myopes (> -6 D), and 45 age-matched healthy controls (age range: 20 - 88 years). SCS was measured in the central retina using a printed version of the chart with 10 radial axes each at a fixed contrast (0.28 - 100% Weber), and with a different spatial frequency in each row of the rings (3 - 60 c/°). In glaucoma suspects and controls, SCS was also measured at a fixed frequency of 1.5 c/° at 12 peripheral retinal locations (5°, 10°, and 15° eccentricities; each at 45°, 135°, 225°, and 345° meridians). Measurements were performed in photopic (~123 cd.m-2) and mesopic (~1 cd.m-2) lighting.

Results : All participants with eye conditions had a 6/6 visual acuity in photopic lighting at ~18% contrast, but did not reach 6/6 at 100% contrast in mesopic lighting. Compared to healthy controls, SCS was significantly lower in AMD at 3, 6, 8, and 12 c/° with greater reductions in mesopic lighting. In patients with diabetes, SCS was significantly reduced at 6 and 8 c/°, and in high myopia at all tested frequencies (3 - 60 c/°). Glaucoma suspects had normal central SCS but exhibited reduced peripheral SCS, with greater reductions in mesopic lighting. In healthy controls, the SCS function was low pass, with a generalised downward shift in mesopic lighting described by a linear function where Mesopic SCS = 1.25*Photopic SCS-1.38 (log units).

Conclusions : The spatial contrast vision chart detects frequency-selective contrast deficits in the early stages of central and peripheral retinal and optic nerve abnormalities in patients with normal high contrast visual acuity. The pattern of spatial vision loss is disease dependent. Additionally, we provide a simple model for predicting mesopic SCS from photopic SCS, relevant in diseases where mesopic vision offers increased sensitivity to the presence of subtle vision deficits.

This abstract was presented at the 2024 ARVO Annual Meeting, held in Seattle, WA, May 5-9, 2024.

×
×

This PDF is available to Subscribers Only

Sign in or purchase a subscription to access this content. ×

You must be signed into an individual account to use this feature.

×